While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

A trial has found that the drug is twice as effective as existing treatments at extending the lives of patients with ...

A new three-drug combination could help women with a common form of aggressive breast cancer live longer, research suggests.

Rare cancer gene TP53 found in 23 out of 67 donor-conceived children * 10 children have already developed cancer, including ...

A rare genetic mutation in a European sperm donor has reportedly caused cancer in 10 children, highlighting the need for ...

Pfizer Inc. (NYSE: PFE) today announced statistically significant and clinically meaningful survival results from the Phase 3 ...

The type of avian flu infection present at a B.C. ostrich farm where a cull is planned is a mutation not seen elsewhere in ...

First-line treatment with the triplet combination of encorafenib, cetuximab and mFOLFOX6 significantly improved survival ...

A new drug combination has been shown to double survival time for patients with a particularly aggressive type of colorectal ...

An online platform may help increase access to and reduce barriers associated with germline testing for individuals with cancer, according to findings presented at ASCO Annual Meeting.An analysis of ...

MK-1084, Merck’s investigational KRAS G12C inhibitor, showed a manageable safety profile along with antitumor activity in the ...

A multiyear investigation pieced together ancient DNA from strains of the plague, bringing together researchers from across ...